Lotilaner ophthalmic solution 0.25% for Demodex blepharitis: randomized, vehicle-controlled, multicenter, phase 3 trial (Saturn-2). Supplement figure 1: patient disposition flow chart. Ophthalmology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback